Applications of biosensors in Alzheimer's disease diagnosis

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible cognitive decline. Currently, it affects 36 million people and due to population ageing it is estimated that in 2030 disease incidence will reach 60 million individuals. The precise diagnosi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Talanta (Oxford) 2020-04, Vol.210, p.120644-120644, Article 120644
Hauptverfasser: Brazaca, Laís Canniatti, Sampaio, Isabella, Zucolotto, Valtencir, Janegitz, Bruno Campos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 120644
container_issue
container_start_page 120644
container_title Talanta (Oxford)
container_volume 210
creator Brazaca, Laís Canniatti
Sampaio, Isabella
Zucolotto, Valtencir
Janegitz, Bruno Campos
description Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible cognitive decline. Currently, it affects 36 million people and due to population ageing it is estimated that in 2030 disease incidence will reach 60 million individuals. The precise diagnosis of AD is still a complex task, being mainly performed by cerebrospinal fluid (CSF) analysis or neuroimaging techniques such as positron emission tomography (PET) and magnetic resonance imaging (MRI). Despite being effective these techniques are expensive, time-consuming and not accessible for most part of the population. In this scenario biosensors are presented as promising alternatives for simple, rapid and low cost diagnosis of AD. In this revision we summarize the recent advances on biosensors that brings more accessibility to AD diagnosis. We introduce the most used biorecognition elements in miniaturized biosensing systems as well as AD biomarkers present in CSF, in plasma and in genetic material which can be used for disease identification even in early stages. The recent developed biosensors for AD diagnosis using optical, electrochemical and colorimetric techniques as well as their strategies and analytical performances are discussed. Advancements in signal amplification methodologies with nanomaterials to increase biosensors sensitivity are also presented. This review highlights the potential of biosensors to be used as an accurate and portable tool to improve the early AD diagnosis. [Display omitted] •Alzheimer’s disease (AD) is the most common degenerative disorder in the world.•We present the state-of-the-art of biosensors for AD diagnosis.•Devices applying diverse biorecognition elements and various categoties of AD biomarkers are presented.•Recent Advancements in signal amplification and the future of biosensors in AD point-of-care diagnosis are discussed.•From the best of our knowledge, this review offers the broadest panorama of the state-of-the-art in biosensors for AD.
doi_str_mv 10.1016/j.talanta.2019.120644
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2347511515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039914019312779</els_id><sourcerecordid>2347511515</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-176fc4d34aca1861c4745231718e4bede3a9c94833c1e029ca71c44ffda74df93</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwCaDsYJPgiZ04EQtUVbykSmxgbbnOBFwlcfGkSPD1pEphy-puzszVPYydA0-AQ369TnrTmK43ScqhTCDluZQHbAqFErHIlDhkU85FGZcg-YSdEK0556ng4phNBJSFSkFO2c18s2mcNb3zHUW-jlbOE3bkA0Wui-bN9zu6FsMlRZUjNIRDmrfOk6NTdlSbhvBsnzP2en_3sniMl88PT4v5MrYiz_oYVF5bWQlprIEiByuVzFIBCgqUK6xQmNKWshDCAvK0tEYNjKzryihZ1aWYsavx7yb4jy1Sr1tHFpthPvot6VRIlQFkkA1oNqI2eKKAtd4E15rwpYHrnTe91ntveudNj96Gu4t9xXbVYvV39StqAG5HAIehnw6DJuuws1i5gLbXlXf_VPwAtLKArw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2347511515</pqid></control><display><type>article</type><title>Applications of biosensors in Alzheimer's disease diagnosis</title><source>Elsevier ScienceDirect Journals</source><creator>Brazaca, Laís Canniatti ; Sampaio, Isabella ; Zucolotto, Valtencir ; Janegitz, Bruno Campos</creator><creatorcontrib>Brazaca, Laís Canniatti ; Sampaio, Isabella ; Zucolotto, Valtencir ; Janegitz, Bruno Campos</creatorcontrib><description>Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible cognitive decline. Currently, it affects 36 million people and due to population ageing it is estimated that in 2030 disease incidence will reach 60 million individuals. The precise diagnosis of AD is still a complex task, being mainly performed by cerebrospinal fluid (CSF) analysis or neuroimaging techniques such as positron emission tomography (PET) and magnetic resonance imaging (MRI). Despite being effective these techniques are expensive, time-consuming and not accessible for most part of the population. In this scenario biosensors are presented as promising alternatives for simple, rapid and low cost diagnosis of AD. In this revision we summarize the recent advances on biosensors that brings more accessibility to AD diagnosis. We introduce the most used biorecognition elements in miniaturized biosensing systems as well as AD biomarkers present in CSF, in plasma and in genetic material which can be used for disease identification even in early stages. The recent developed biosensors for AD diagnosis using optical, electrochemical and colorimetric techniques as well as their strategies and analytical performances are discussed. Advancements in signal amplification methodologies with nanomaterials to increase biosensors sensitivity are also presented. This review highlights the potential of biosensors to be used as an accurate and portable tool to improve the early AD diagnosis. [Display omitted] •Alzheimer’s disease (AD) is the most common degenerative disorder in the world.•We present the state-of-the-art of biosensors for AD diagnosis.•Devices applying diverse biorecognition elements and various categoties of AD biomarkers are presented.•Recent Advancements in signal amplification and the future of biosensors in AD point-of-care diagnosis are discussed.•From the best of our knowledge, this review offers the broadest panorama of the state-of-the-art in biosensors for AD.</description><identifier>ISSN: 0039-9140</identifier><identifier>EISSN: 1873-3573</identifier><identifier>DOI: 10.1016/j.talanta.2019.120644</identifier><identifier>PMID: 31987214</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Alzheimer's disease ; Analytical chemistry ; Biosensors ; Electrochemistry ; Optical biosensors</subject><ispartof>Talanta (Oxford), 2020-04, Vol.210, p.120644-120644, Article 120644</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-176fc4d34aca1861c4745231718e4bede3a9c94833c1e029ca71c44ffda74df93</citedby><cites>FETCH-LOGICAL-c365t-176fc4d34aca1861c4745231718e4bede3a9c94833c1e029ca71c44ffda74df93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0039914019312779$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31987214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brazaca, Laís Canniatti</creatorcontrib><creatorcontrib>Sampaio, Isabella</creatorcontrib><creatorcontrib>Zucolotto, Valtencir</creatorcontrib><creatorcontrib>Janegitz, Bruno Campos</creatorcontrib><title>Applications of biosensors in Alzheimer's disease diagnosis</title><title>Talanta (Oxford)</title><addtitle>Talanta</addtitle><description>Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible cognitive decline. Currently, it affects 36 million people and due to population ageing it is estimated that in 2030 disease incidence will reach 60 million individuals. The precise diagnosis of AD is still a complex task, being mainly performed by cerebrospinal fluid (CSF) analysis or neuroimaging techniques such as positron emission tomography (PET) and magnetic resonance imaging (MRI). Despite being effective these techniques are expensive, time-consuming and not accessible for most part of the population. In this scenario biosensors are presented as promising alternatives for simple, rapid and low cost diagnosis of AD. In this revision we summarize the recent advances on biosensors that brings more accessibility to AD diagnosis. We introduce the most used biorecognition elements in miniaturized biosensing systems as well as AD biomarkers present in CSF, in plasma and in genetic material which can be used for disease identification even in early stages. The recent developed biosensors for AD diagnosis using optical, electrochemical and colorimetric techniques as well as their strategies and analytical performances are discussed. Advancements in signal amplification methodologies with nanomaterials to increase biosensors sensitivity are also presented. This review highlights the potential of biosensors to be used as an accurate and portable tool to improve the early AD diagnosis. [Display omitted] •Alzheimer’s disease (AD) is the most common degenerative disorder in the world.•We present the state-of-the-art of biosensors for AD diagnosis.•Devices applying diverse biorecognition elements and various categoties of AD biomarkers are presented.•Recent Advancements in signal amplification and the future of biosensors in AD point-of-care diagnosis are discussed.•From the best of our knowledge, this review offers the broadest panorama of the state-of-the-art in biosensors for AD.</description><subject>Alzheimer's disease</subject><subject>Analytical chemistry</subject><subject>Biosensors</subject><subject>Electrochemistry</subject><subject>Optical biosensors</subject><issn>0039-9140</issn><issn>1873-3573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOwzAQRS0EoqXwCaDsYJPgiZ04EQtUVbykSmxgbbnOBFwlcfGkSPD1pEphy-puzszVPYydA0-AQ369TnrTmK43ScqhTCDluZQHbAqFErHIlDhkU85FGZcg-YSdEK0556ng4phNBJSFSkFO2c18s2mcNb3zHUW-jlbOE3bkA0Wui-bN9zu6FsMlRZUjNIRDmrfOk6NTdlSbhvBsnzP2en_3sniMl88PT4v5MrYiz_oYVF5bWQlprIEiByuVzFIBCgqUK6xQmNKWshDCAvK0tEYNjKzryihZ1aWYsavx7yb4jy1Sr1tHFpthPvot6VRIlQFkkA1oNqI2eKKAtd4E15rwpYHrnTe91ntveudNj96Gu4t9xXbVYvV39StqAG5HAIehnw6DJuuws1i5gLbXlXf_VPwAtLKArw</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Brazaca, Laís Canniatti</creator><creator>Sampaio, Isabella</creator><creator>Zucolotto, Valtencir</creator><creator>Janegitz, Bruno Campos</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200401</creationdate><title>Applications of biosensors in Alzheimer's disease diagnosis</title><author>Brazaca, Laís Canniatti ; Sampaio, Isabella ; Zucolotto, Valtencir ; Janegitz, Bruno Campos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-176fc4d34aca1861c4745231718e4bede3a9c94833c1e029ca71c44ffda74df93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Alzheimer's disease</topic><topic>Analytical chemistry</topic><topic>Biosensors</topic><topic>Electrochemistry</topic><topic>Optical biosensors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brazaca, Laís Canniatti</creatorcontrib><creatorcontrib>Sampaio, Isabella</creatorcontrib><creatorcontrib>Zucolotto, Valtencir</creatorcontrib><creatorcontrib>Janegitz, Bruno Campos</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Talanta (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brazaca, Laís Canniatti</au><au>Sampaio, Isabella</au><au>Zucolotto, Valtencir</au><au>Janegitz, Bruno Campos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Applications of biosensors in Alzheimer's disease diagnosis</atitle><jtitle>Talanta (Oxford)</jtitle><addtitle>Talanta</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>210</volume><spage>120644</spage><epage>120644</epage><pages>120644-120644</pages><artnum>120644</artnum><issn>0039-9140</issn><eissn>1873-3573</eissn><abstract>Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible cognitive decline. Currently, it affects 36 million people and due to population ageing it is estimated that in 2030 disease incidence will reach 60 million individuals. The precise diagnosis of AD is still a complex task, being mainly performed by cerebrospinal fluid (CSF) analysis or neuroimaging techniques such as positron emission tomography (PET) and magnetic resonance imaging (MRI). Despite being effective these techniques are expensive, time-consuming and not accessible for most part of the population. In this scenario biosensors are presented as promising alternatives for simple, rapid and low cost diagnosis of AD. In this revision we summarize the recent advances on biosensors that brings more accessibility to AD diagnosis. We introduce the most used biorecognition elements in miniaturized biosensing systems as well as AD biomarkers present in CSF, in plasma and in genetic material which can be used for disease identification even in early stages. The recent developed biosensors for AD diagnosis using optical, electrochemical and colorimetric techniques as well as their strategies and analytical performances are discussed. Advancements in signal amplification methodologies with nanomaterials to increase biosensors sensitivity are also presented. This review highlights the potential of biosensors to be used as an accurate and portable tool to improve the early AD diagnosis. [Display omitted] •Alzheimer’s disease (AD) is the most common degenerative disorder in the world.•We present the state-of-the-art of biosensors for AD diagnosis.•Devices applying diverse biorecognition elements and various categoties of AD biomarkers are presented.•Recent Advancements in signal amplification and the future of biosensors in AD point-of-care diagnosis are discussed.•From the best of our knowledge, this review offers the broadest panorama of the state-of-the-art in biosensors for AD.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31987214</pmid><doi>10.1016/j.talanta.2019.120644</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-9140
ispartof Talanta (Oxford), 2020-04, Vol.210, p.120644-120644, Article 120644
issn 0039-9140
1873-3573
language eng
recordid cdi_proquest_miscellaneous_2347511515
source Elsevier ScienceDirect Journals
subjects Alzheimer's disease
Analytical chemistry
Biosensors
Electrochemistry
Optical biosensors
title Applications of biosensors in Alzheimer's disease diagnosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T02%3A40%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Applications%20of%20biosensors%20in%20Alzheimer's%20disease%20diagnosis&rft.jtitle=Talanta%20(Oxford)&rft.au=Brazaca,%20La%C3%ADs%20Canniatti&rft.date=2020-04-01&rft.volume=210&rft.spage=120644&rft.epage=120644&rft.pages=120644-120644&rft.artnum=120644&rft.issn=0039-9140&rft.eissn=1873-3573&rft_id=info:doi/10.1016/j.talanta.2019.120644&rft_dat=%3Cproquest_cross%3E2347511515%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2347511515&rft_id=info:pmid/31987214&rft_els_id=S0039914019312779&rfr_iscdi=true